BCIM
TARO

British Columbia Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

British Columbia Investment Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,400
Closed -$383K – 704
2017
Q3 		$383K Buy
3,400
+1,600
+89% +$174K ﹤0.01% 688
2017
Q2 		$202K Hold
1,800
– – ﹤0.01% 694
2017
Q1 		$210K Buy
+1,800
New +$199K ﹤0.01% 688

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

British Columbia Investment Management's TARO Position: Q4 2017 in Review

British Columbia Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 3,400 shares — an estimated $383K sold.

British Columbia Investment Management first reported a position in TARO in Q1 2017 and held it in 3 quarters. The position peaked at $383K in Q3 2017. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

  • British Columbia Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
  • British Columbia Investment Management sold 3,400 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $383K.
  • British Columbia Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2017 and held it in 3 quarters.
  • British Columbia Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $383K in Q3 2017.
  • 127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on British Columbia Investment Management's 13F filing for Q4 2017, filed 20 Feb 2018.